Biotech startup Ray raises $100M for vision-restoring gene therapies
Bio Pharma Dive
MAY 16, 2023
Founded in early 2021, the company is using optogenetics to design treatments that could work across disease genotypes and in the later stages of vision loss.
Let's personalize your content